Top Clinical Trials companies in United Kingdom by Net Income Margin

This ranking features the top 12 Clinical Trials companies in United Kingdom ranked by Net Income Margin, averaging a Net Income Margin of -2,172.58%, for January 15, 2025.
#
Name
Net Income Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
28.75%
Dec. 31, 2023 USD 0.21 6.16%

United Kingdom

2
-22.17%
Dec. 31, 2023 USD 28.56 -4.90%

United Kingdom

3
-25.96%
Dec. 31, 2023 USD 0.49 0.09%

United Kingdom

4
-107.31%
Dec. 31, 2023 USD 0.62 -2.80%

United Kingdom

5
-170.51%
Dec. 31, 2023 USD 5.61 -4.92%

United Kingdom

6
-294.66%
Dec. 31, 2023 USD 3.06 -8.38%

United Kingdom

7
-324.81%
Dec. 31, 2023 USD 0.04 0.09%

United Kingdom

8
-669.72%
Dec. 31, 2023 USD 14.81 -2.31%

United Kingdom

9
-862.19%
Dec. 31, 2023 USD 0.05 -16.59%

United Kingdom

10
-2,204.65%
Dec. 31, 2023 USD 14.84 -2.75%

United Kingdom

11
-9,145.51%
Dec. 31, 2023 USD 0.95 0.80%

United Kingdom

12
-12,272.26%
Dec. 31, 2023 USD 2.21 -3.91%

United Kingdom

Frequently Asked Questions
  • Which Clinical Trials company in United Kingdom has the highest Net Income Margin ?

    The Clinical Trials company in United Kingdom with the highest Net Income Margin is hVIVO plc (LSE: HVO.L) at 28.75%.

  • Which Clinical Trials company in United Kingdom has the lowest Net Income Margin ?

    The Clinical Trials company in United Kingdom with the lowest Net Income Margin is Autolus Therapeutics plc (NasdaqGS: AUTL) at -12,272.26%.